Product Information
NORETHINDRONE 5 MG TABLET is a generic product labeled by Ingenus Pharmaceuticals LLC, priced at $0.2898 per EA under NDC 50742026750. Its NADAC has been published 356 times since Dec 11, 2019.
FDA first approved this application on Nov 5, 2018. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
5 mg/1
Manufacturer
Ingenus Pharmaceuticals LLCNDC
50742026750
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
NORETHINDRONE ACETATEApproval Type
Generic (ANDA)
FDA Application
ANDA206490FDA Approved
11/5/2018
TE Code
AB
On Market Since
8/29/2019
Pharmacological Classes
Price Statistics
The NADAC for NORETHINDRONE 5 MG TABLET has been published 356 times since Dec 11, 2019, and over the history we have for it it has declined 68.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2898 per EA |
|---|---|
| All-time high | $1.0386 (Feb 12, 2020) |
| All-time low | $0.2135 (Nov 20, 2024) |
| 52-week high | $0.3028 |
| 52-week low | $0.2895 |
| Median price | $0.3461 |
| Average price | $0.4834 |
| Largest weekly change | +37.3% (Aug 21, 2024) |
| Weeks tracked | 356 |
| Tracking since | Dec 11, 2019 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the norethindrone acetate market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Ingenus Pharmaceuticals LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
norethindrone acetate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Progestin class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of NORETHINDRONE 5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for NORETHINDRONE 5 MG TABLET, manufactured by Ingenus Pharmaceuticals LLC, is $0.2898 per EA (NDC 50742026750), effective Sep 30, 2026.
How has the price of NORETHINDRONE 5 MG TABLET changed over time?
Over the history we have for it, the NADAC for NORETHINDRONE 5 MG TABLET has declined 68.7%. It has been tracked across 356 weekly CMS publications since Dec 11, 2019.
What are the highest and lowest recorded NADAC prices for NORETHINDRONE 5 MG TABLET?
Since Dec 11, 2019, the NADAC for NORETHINDRONE 5 MG TABLET has ranged from a low of $0.2135 (Nov 20, 2024) to a high of $1.0386 (Feb 12, 2020), with a median of $0.3461 per EA.
Are there cheaper alternatives to NORETHINDRONE 5 MG TABLET?
No other NADAC-published product currently shares the active ingredient and strength of NORETHINDRONE 5 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures NORETHINDRONE 5 MG TABLET?
NORETHINDRONE 5 MG TABLET (NDC 50742026750) is labeled by Ingenus Pharmaceuticals LLC, and CMS classifies it as a generic product.